<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32928301</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Aggregate-selective antibody attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice.</ArticleTitle><Pagination><StartPage>161</StartPage><MedlinePgn>161</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">161</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-020-01032-2</ELocationID><Abstract><AbstractText>Increasing evidence suggests that propagation of the motor neuron disease amyotrophic lateral sclerosis (ALS) involves the pathogenic aggregation of disease-associated proteins that spread in a prion-like manner. We have identified two aggregate strains of human superoxide dismutase 1 (hSOD1) that arise in the CNS of transgenic mouse models of SOD1-mediated ALS. Both strains transmit template-directed aggregation and premature fatal paralysis when inoculated into the spinal cord of adult hSOD1 transgenic mice. This spread of pathogenic aggregation could be a potential target for immunotherapeutic intervention. Here we generated mouse monoclonal antibodies (mAbs) directed to exposed epitopes in hSOD1 aggregate strains and identified an aggregate selective mAb that targets the aa 143-153 C-terminal extremity of hSOD1 (&#x3b1;SOD1<sup>143-153</sup>). Both pre-incubation of seeds with &#x3b1;SOD1<sup>143-153</sup> prior to inoculation, and weekly intraperitoneal (i.p.) administration attenuated transmission of pathogenic aggregation and prolonged the survival of seed-inoculated hSOD1<sup>G85R</sup> Tg mice. In contrast, administration of a mAb targeting aa 65-72 (&#x3b1;SOD1<sup>65-72</sup>), which exhibits high affinity towards monomeric disordered hSOD1, had an adverse effect and aggravated seed induced premature ALS-like disease. Although the mAbs reached similar concentrations in CSF, only &#x3b1;SOD1<sup>143-153</sup> was found in association with aggregated hSOD1 in spinal cord homogenates. Our results suggest that an aggregate-selective immunotherapeutic approach may suppress seeded transmission of pathogenic aggregation in ALS. However, long-term administration of &#x3b1;SOD1<sup>143-153</sup> was unable to prolong the lifespan of non-inoculated hSOD1<sup>G85R</sup> Tg mice. Thus, spontaneously initiated hSOD1 aggregation in spinal motor neurons may be poorly accessible to therapeutic antibodies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marklund</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolender</LastName><ForeName>Anna-Lena</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bidhendi</LastName><ForeName>Elaheh E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zetterstr&#xf6;m</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Clinical Chemistry, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xe4;nnstr&#xf6;m</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Pathology, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marklund</LastName><ForeName>Stefan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Medical Biosciences, Clinical Chemistry, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilthorpe</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Integrative Medical Biology, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordstr&#xf6;m</LastName><ForeName>Ulrika</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-7757-2344</Identifier><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, 901 87, Ume&#xe5;, Sweden. ulrika.nordstrom@umu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">Prion-like</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">Template directed aggregation</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32928301</ArticleId><ArticleId IdType="pmc">PMC7488686</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-01032-2</ArticleId><ArticleId IdType="pii">10.1186/s40478-020-01032-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nat Rev Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, Borchelt DR. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791&#x2013;803. doi: 10.1007/s00401-014-1342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI, Fromholt SE, O&#x2019;Neal VM, Diamond JH, Borchelt DR. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol. 2016;131:103&#x2013;114. doi: 10.1007/s00401-015-1514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1514-0</ArticleId><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, Guido T, Hoenow K, Hu K, Johnson-Wood K, Khan K, Kholodenko D, Lee C, Lee M, Motter R, Nguyen M, Reed A, Schenk D, Tang P, Vasquez N, Seubert P, Yednock T. Epitope and isotype specificities of antibodies to &#x3b2;-amyloid peptide for protection against Alzheimer&#x2019;s disease-like neuropathology. Proc Natl Acad Sci. 2003;100:2023. doi: 10.1073/pnas.0436286100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0436286100</ArticleId><ArticleId IdType="pmc">PMC149952</ArticleId><ArticleId IdType="pubmed">12566568</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkler C, O&#x2019;Neil AL, Slepian S, Qian F, Weinreb PH, Rubin LL. Aggregated SOD1 causes selective death of cultured human motor neurons. Sci Rep. 2018;8:16393. doi: 10.1038/s41598-018-34759-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34759-z</ArticleId><ArticleId IdType="pmc">PMC6219543</ArticleId><ArticleId IdType="pubmed">30401824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh J, Zetterstrom P, Andersen PM, Brannstrom T, Graffmo KS, Jonsson PA, Lang L, Danielsson J, Oliveberg M, Marklund SL. Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping. Proc Natl Acad Sci USA. 2015;112:4489&#x2013;4494. doi: 10.1073/pnas.1419228112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1419228112</ArticleId><ArticleId IdType="pmc">PMC4394267</ArticleId><ArticleId IdType="pubmed">25802384</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi EE, Bergh J, Zetterstrom P, Andersen PM, Marklund SL, Brannstrom T. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J Clin Invest. 2016;126:2249&#x2013;2253. doi: 10.1172/JCI84360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84360</ArticleId><ArticleId IdType="pmc">PMC4887173</ArticleId><ArticleId IdType="pubmed">27140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi EE, Bergh J, Zetterstr&#xf6;m P, Forsberg K, Pakkenberg B, Andersen PM, Marklund SL, Br&#xe4;nnstr&#xf6;m T. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 2018 doi: 10.1007/s00401-018-1915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, Frosch MP, Agar JN, Julien JP, Brady ST, Brown RH., Jr Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/S0896-6273(00)80272-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80272-X</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot JM. De la scl&#xe9;rose lat&#xe9;rale amyotrophique. Prog Med. 1874;2:325&#x2013;327.</Citation></Reference><Reference><Citation>Chia R, Tattum MH, Jones S, Collinge J, Fisher EM, Jackson GS. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PloS ONE. 2010;5:e10627. doi: 10.1371/journal.pone.0010627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010627</ArticleId><ArticleId IdType="pmc">PMC2869360</ArticleId><ArticleId IdType="pubmed">20498711</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, Hauw JJ, Meininger V. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59&#x2013;62. doi: 10.1080/17482960701656940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701656940</ArticleId><ArticleId IdType="pubmed">17924236</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Graffmo K, Pakkenberg B, Weber M, Nielsen M, Marklund S, Brannstrom T, Andersen PM. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J Neurol Neurosurg Psychiatry. 2019;90:861&#x2013;869. doi: 10.1136/jnnp-2018-319386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319386</ArticleId><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Brannstrom T. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE. 2010;5:11552. doi: 10.1371/journal.pone.0011552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Guest WC, Yanai A, Pokrishevsky E, O&#x2019;Neill MA, Gibbs E, Semenchenko V, Yousefi M, Wishart DS, Plotkin SS, Cashman NR. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci USA. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O&#x2019;Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L, Kumita JR, Luheshi LM, Yousefi M, Coleman BM, Hill AF, Plotkin SS, Mackenzie IR, Cashman NR. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natal Acad Sci USA. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F, Soucy G, Larivi&#xe8;re R, Julien J-P. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem. 2010;113:1188&#x2013;1199. doi: 10.1111/j.1471-4159.2010.06683.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06683.x</ArticleId><ArticleId IdType="pubmed">20345765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M, Pu H, Chiu A, Dal Canto M, Polchow C, Alexander D, Caliendo J, Hentati A, Kwon Y, Deng H, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittner A, Bertz J, Suh LS, Stevens CH, G&#xf6;tz J, Ittner LM. Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice. J Neurochem. 2014;132:135&#x2013;145. doi: 10.1111/jnc.12821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12821</ArticleId><ArticleId IdType="pubmed">25041093</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Brannstrom T, Nilsson P, Andersen PM, Marklund SL. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J Neuropathol Exp Neurol. 2006;65:1126&#x2013;1136. doi: 10.1097/01.jnen.0000248545.36046.3c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248545.36046.3c</ArticleId><ArticleId IdType="pubmed">17146286</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin I, Forsgren E, Lehmann M. The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension. Acta Neuropathol. 2019;138(1):85&#x2013;101. doi: 10.1007/s00401-019-01986-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01986-1</ArticleId><ArticleId IdType="pmc">PMC6570705</ArticleId><ArticleId IdType="pubmed">30863976</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H-N, Tjostheim S, DaSilva K, Taylor D, Zhao B, Rakhit R, Brown M, Chakrabartty A, McLaurin J, Robertson J. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J Neurosci. 2012;32:8791. doi: 10.1523/JNEUROSCI.5053-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5053-11.2012</ArticleId><ArticleId IdType="pmc">PMC6622344</ArticleId><ArticleId IdType="pubmed">22745481</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Duff K. A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse. J Vis Exp. 2008 doi: 10.3791/960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/960</ArticleId><ArticleId IdType="pmc">PMC2762909</ArticleId><ArticleId IdType="pubmed">19066529</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M, Welt T, Wirth F, Montrasio F, Preisig D, McAfoose J, Vieira FG, Kulic L, Sp&#xe4;ni C, Stehle T, Perrin S, Weber M, Hock C, Nitsch RM, Grimm J. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Sci Transl Med. 2018;10:3924. doi: 10.1126/scitranslmed.aah3924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah3924</ArticleId><ArticleId IdType="pubmed">30518612</ArticleId></ArticleIdList></Reference><Reference><Citation>Malyala P, Singh M. Endotoxin limits in formulations for preclinical research. J Pharm Sci. 2008;97:2041&#x2013;2044. doi: 10.1002/jps.21152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jps.21152</ArticleId><ArticleId IdType="pubmed">17847072</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C, O&#x2019;Brien J, Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci USA. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, Montrasio F, Pattamatta A, Tusi SK, Bardhi O, Meyer KD, Hayes L, Nakamura K, Banez-Coronel M, Coyne A, Guo S, Laboissonniere LA, Gu Y, Narayanan S, Smith B, Nitsch RM, Kankel MW, Rushe M, Rothstein J, Zu T, Grimm J, Ranum LPW (2020) Antibody therapy targeting RAN proteins rescues C9 ALS/FTD phenotypes in C9orf72 mouse model. Neuron. 10.1016/j.neuron.2019.11.007</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391607</ArticleId><ArticleId IdType="pubmed">31831332</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, Lehmann M, Beaudin M, Nordstr&#xf6;m U, Saikali S, Julien J-P, Gilthorpe JD, Marklund SL, Cashman NR, Andersen PM, Forsberg K, Dupr&#xe9; N, Gould P, Br&#xe4;nnstr&#xf6;m T, Gros-Louis F. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci Rep. 2018;8:14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Grad LI, Cashman NR. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion. Sci Rep. 2016;6:22155. doi: 10.1038/srep22155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22155</ArticleId><ArticleId IdType="pmc">PMC4772009</ArticleId><ArticleId IdType="pubmed">26926802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E, Hong RH, Mackenzie IR, Cashman NR. Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. PLoS ONE. 2017;12:e0184384&#x2013;e0184384. doi: 10.1371/journal.pone.0184384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184384</ArticleId><ArticleId IdType="pmc">PMC5587256</ArticleId><ArticleId IdType="pubmed">28877271</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Cleveland DW. The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 2011;147:498&#x2013;508. doi: 10.1016/j.cell.2011.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.011</ArticleId><ArticleId IdType="pmc">PMC3220614</ArticleId><ArticleId IdType="pubmed">22036560</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Jr, Scott RW, Snider WD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet. 1996;13:43&#x2013;47. doi: 10.1038/ng0596-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0596-43</ArticleId><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7:253. doi: 10.3389/fncel.2013.00253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;bado J, Casanovas A, Rodrigo H, Arqu&#xe9; G, Esquerda JE. Adverse effects of a SOD1-peptide immunotherapy on SOD1G93A mouse slow model of amyotrophic lateral sclerosis. Neuroscience. 2015;310:38&#x2013;50. doi: 10.1016/j.neuroscience.2015.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.09.027</ArticleId><ArticleId IdType="pubmed">26384962</ArticleId></ArticleIdList></Reference><Reference><Citation>Schachman HK (1957) [2] Ultracentrifugation, diffusion, and viscometry. In: Methods in enzymology, vol 4. Academic Press, London, pp 32&#x2013;103. 10.1016/0076-6879(57)04050-1</Citation></Reference><Reference><Citation>Sevigny J, Chiao P, Bussi&#xe8;re T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O&#x2019;Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A. The antibody aducanumab reduces A&#x3b2; plaques in Alzheimer&#x2019;s disease. Nature. 2016;537:50. doi: 10.1038/nature19323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19323</ArticleId><ArticleId IdType="pubmed">27582220</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, Christy D, Shyu CC, Moon KM, Fernando S, Gidden Z, Cowan CM, Ban Y, Stacey RG, Grad LI, McAlary L, Mackenzie IR, Foster LJ, Cashman NR. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)(G93A) ALS mice originate from astrocytes and neurons and carry misfolded SOD1. J Biol Chem. 2019;294:3744&#x2013;3759. doi: 10.1074/jbc.RA118.004825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004825</ArticleId><ArticleId IdType="pmc">PMC6416428</ArticleId><ArticleId IdType="pubmed">30635404</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi S, Fujiwara N, Ido A, Oono M, Takeuchi Y, Tateno M, Suzuki K, Takahashi R, Tooyama I, Taniguchi N, Julien J-P, Urushitani M. Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice. J Neuropathol Exp Neurol. 2010;69:1044&#x2013;1056. doi: 10.1097/NEN.0b013e3181f4a90a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181f4a90a</ArticleId><ArticleId IdType="pubmed">20838241</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Ezzi SA, Julien J-P. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad of Sci. 2007;104:2495. doi: 10.1073/pnas.0606201104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606201104</ArticleId><ArticleId IdType="pmc">PMC1790867</ArticleId><ArticleId IdType="pubmed">17277077</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihofen A, Liu Y, Arndt JW, Huy C, Quan C, Smith BA, Baeriswyl J-L, Cavegn N, Senn L, Su L, Marsh G, Auluck PK, Montrasio F, Nitsch RM, Hirst WD, Cedarbaum JM, Pepinsky RB, Grimm J, Weinreb PH. Development of an aggregate-selective, human-derived &#x3b1;-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson&#x2019;s disease models. Neurobiol Dis. 2019;124:276&#x2013;288. doi: 10.1016/j.nbd.2018.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.10.016</ArticleId><ArticleId IdType="pubmed">30381260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995 doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood ME, Griebel P, Huizenga ML, Lockwood S, Hansen C, Potter A, Cashman N, Mapletoft JW, Napper S. Accelerated onset of chronic wasting disease in elk (Cervus canadensis) vaccinated with a PrPSc-specific vaccine and housed in a prion contaminated environment. Vaccine. 2018;36:7737&#x2013;7743. doi: 10.1016/j.vaccine.2018.10.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.10.057</ArticleId><ArticleId IdType="pubmed">30414779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B, Marciniuk K, Gibbs E, Yousefi M, Napper S, Cashman NR. Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1. Vaccine. 2019;37:4920&#x2013;4927. doi: 10.1016/j.vaccine.2019.07.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.07.044</ArticleId><ArticleId IdType="pubmed">31324499</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>